Biopico Systems Inc is a leader in the emerging field of interacting multiple organ systems or microphysiological systems technology. This patented technology will accurately recapitulate human physiology by engineering physiological flow and organs crosstalk microenvironment for pharmacological and toxicological drug screening. Biopico’s organ technology stands out for its efficient unidirectional recirculation using pumpless tubeless flow, alongside provisions for high-throughput organ culture and assays. Currently, Biopico is focused on validating multiorgan-based drug screening, particularly for Alzheimer's Disease. Its future plans include expanding to multiple organs and applications, such as functional monitoring of organs, to provide holistic solutions for the pharmaceutical industry. This will revolutionize in vitro preclinical biomedical research for drug discovery and disease pathology. Human multi-organ system is the future of drug discovery with high efficacy and safety